Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

After listening to Podcast The Drive #117 – Stan

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155299
(Total Views: 740)
Posted On: 07/13/2020 1:07:45 PM
Posted By: bugeater
After listening to Podcast The Drive #117 – Stanley Perlman, M.D., Ph.D.: Insights from a coronavirus expert on COVID-19 I sent Bruce Patterson's manuscript -- Disruption of the CCL5/RANTES-CCR5 Pathway-- https://www.medrxiv.org/content/10.1101/2020....20084673v1 to Dr. Perlman:

I found it interesting that he had already read it, and like a good scientist was cautious and yet open to the fact that CCL5 COULD be the most important target.
Probably more important to us as CYDY bagholders... we have safety data and HOPEFULLY agood blinded study results showing that it works and can be first to market, which is obviously critical to treatment NOW.

He responded with the below.

"Craig,
Thanks for sending this manuscript. I had seen it and I think that it points out the importance of tempering the immune response. However, whether CCL5 is the most critical target is still an open question, I think."

Stanley Perlman, M.D., Ph.D.
Professor
Department of Microbiology
University of Iowa
STANLEY PERLMAN, M.D., PH.D.
Stanley is a professor of microbiology and immunology along with being a professor of pediatrics and the chair of virology at the University of Iowa. Stanley has researched coronaviruses for nearly four decades and his lab is currently using mouse models for SARS-CoV-1 and SARS-CoV-2, to better understand the more severe diseases that affect humans.

Cheers,
Craig/bugeater PharmD


(2)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us